ATC Group: C10AC02 Colestipol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C10AC02 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C10 Lipid modifying agents
3 C10A Lipid modifying agents, plain
4 C10AC Bile acid sequestrants
5 C10AC02 Colestipol

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 20 g

Active ingredients in C10AC02

Active Ingredient Description
Colestipol

Colestipol is an ion exchange resin which lowers plasma cholesterol through binding with bile acids in the intestinal lumen. It is indicated as adjunctive therapy to diet in the management of patients with elevated cholesterol levels who have not responded adequately to diet.

Related product monographs

Title Information Source Document Type  
COLESTID Granule for oral suspension FDA, National Drug Code (US) MPI, US: SPL/Old
COLESTID Granule for oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
COLESTID Tablet FDA, National Drug Code (US) MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Canada (CA)

Estonia (EE)

Israel (IL)

New Zealand (NZ)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.